03.01.2024 - WATERTOWN, Mass., Jan. 03, 2024 (GLOBE NEWSWIRE) - Acrivon Therapeutics, Inc. (“Acrivon” or “Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage biopharmaceutical company developing precision oncology medicines that it matches to patients . Seite 1
Didier Landais is appointed 4P-Pharma's CEO to lead the company into a new chapter of its development finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
• For the first time, Oxford chemists have generated fluorochemicals – critical for many industries – without the use of hazardous hydrogen fluoride gas.
• The innovative method was inspired by the biomineralization process that forms our teeth and bones.
• The results are published today in the leading journal Science.
collectively referred to as the "Transaction"). The Transaction constituted a reverse takeover of the Company by FTP under applicable securities laws. FTP became a.
/PRNewswire/ Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), an immunology company, today announced the appointment of.